Clinical Trial: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664553) titled 'A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin' on June 18.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)

Study Start Date: July 06

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus

Intervention: DRUG: Elecoglipron

Elecoglipron is administered orally once daily.

DRUG: Placebo

Placebo is...